The United Arab Emirates, through the Emirates Red Crescent (ERC), has sent an aid plane carrying 80,000 COVID-19 vaccines to Mauritania to bolster the country’s efforts in curbing the spread of the virus.
This shipment of medical supplies, which arrived in conjunction with the opening of the Sheikh Mohamed bin Zayed field hospital to treat people infected with the virus, aims to provide greater protection for the vulnerable, the elderly, and those suffering from chronic diseases.
Hamad Ghanem Al Mehairi, UAE Ambassador to Mauritania, stressed the strength of bilateral relations, explaining that the UAE is always present in supporting Mauritania with its humanitarian and development initiatives.
"This health and humanitarian initiative embodies the UAE's approach and continuous efforts to support the brotherly Mauritanian people and provide them with assistance in all fields. For many years, the UAE has undertaken great efforts in Mauritania in various aspects, foremost of which is the interest in the health aspect."
Dr. Mohammed Ateeq Al Falahi, ERC Secretary-General, said that this initiative comes in line with the UAE's efforts to limit the spread of the virus around the world, based on its humanitarian and pioneering role in combating the pandemic.
He stressed that these vaccines will contribute to strengthening preventive and precautionary measures among Mauritanian people, limit the outbreak of the pandemic, and helping to reach the stage of recovery.
To date, the UAE has sent more than 2,200 tonnes of medical supplies to more than 136 countries.
Distributed by APO Group on behalf of United Arab Emirates Ministry of Foreign Affairs&International Cooperation.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
